<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00565890</url>
  </required_header>
  <id_info>
    <org_study_id>nrntokyo</org_study_id>
    <secondary_id>T4VLBWI</secondary_id>
    <nct_id>NCT00565890</nct_id>
  </id_info>
  <brief_title>Supplemental Thyroxine Treatment for Preterm Infants With Hypothyroxinemia</brief_title>
  <official_title>Randomized Controlled Clinical Trial of Thyroxine Supplementation for Very-low-birth-weight Infants With Hypothyroxinemia During the First Month of Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tokyo Women's Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tokyo Metropolitan Bokuto Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tokyo Women's Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In order to determine the efficacy and safety of thyroxine replacement, a randomized clinical
      trial of thyroxine supplementation for VLBW infant with hypothyroxinemia during the first
      month of age is conducted.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective randomized unmasked controlled trial is conducted. Newborn infants with birth
      weight less than 1500g are randomized into thyroxine treatment or un-treatment group.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2005</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Psychomotor development at 1.5 years of age</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Psychomotor development at 3 years of age</measure>
    <time_frame>6 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Somatic growth at 3 years of age</measure>
    <time_frame>6 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospital stay</measure>
    <time_frame>6 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of morbidities during the stay in NICu</measure>
    <time_frame>6 years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Hypothyroxinemia</condition>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No replacement therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>thyroxine</intervention_name>
    <description>thyroxine at the dose of 5 μg/kg-wt /day</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Birth weight: less than 1500g

          -  Gestation: 22 weeks 0 day ≤

          -  Serum free thyroxine level lower than 0.8 ng/dl

          -  Serum thyrotropin lower than 10 μU/ml

          -  Age of between 2 and 4 weeks after birth

          -  Informed consent

        Exclusion Criteria:

          -  any known thyroid disease in mother
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>4 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Satoshi Kusuda, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tokyo Women's Medical Unversity</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maternal and Perinatal Center, Tokyo Women's Medical University</name>
      <address>
        <city>Tokyo</city>
        <zip>162-8666</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2007</study_first_submitted>
  <study_first_submitted_qc>November 29, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2007</study_first_posted>
  <last_update_submitted>June 3, 2013</last_update_submitted>
  <last_update_submitted_qc>June 3, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tokyo Women's Medical University</investigator_affiliation>
    <investigator_full_name>Satoshi Kusuda</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>very low birth weight infant</keyword>
  <keyword>hypothyroxinemia</keyword>
  <keyword>outcomes</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

